85-1438-77 PPARg2, Control Peptide (Peroxisome Proliferator Activated Receptor, gamma 2) 1mg P5505-02A

※お見積書はカートで印刷できます

冷凍 保管・搬送時に冷凍が必要な商品です。

特徴

  • Control Peptide M(1)GETLGDSPIDPESDS(16)C (linear) for P5505-02 anti-PPARg2 (Peroxisome Proliferator Activated Receptor, gamma 2) which detects peroxisome proliferator activated receptor (PPAR) gamma 2 from mouse tissues, but does not detect PPAR alpha or PPAR delta. Immunizing peptide corresponds to amino acid residues 1-16 from human PPAR gamma 2. This sequence is absent in PPAR gamma 1. The sequence is 16 amino acids and is is derived from human PPARg2; this sequence is absent in PPARg1. A COOH-terminal cysteine residue was added for conjugation to KLH.
  • Peroxisome proliferators are non-genotoxic carcinogens which are purported to exert their effect on cells through their interaction with members of the nuclear hormone receptor family, termed peroxisome proliferator activated receptors (PPARs). Nuclear hormone receptors are ligand-dependent intracellular proteins that stimulate transcription of specific genes by binding to specific DNA sequences following activation by the appropriate ligand. Studies indicate that PPARs are activated by peroxisome proliferators such as clofibric acid, nafenopin, and WY-14,643, as well as by some fatty acids. It has also been shown that PPARs can induce transcription of acyl coenzyme A oxidase & cytochrome P450 A6 (CYP450 A6) through interaction with specific response elements. PPAR alpha is activated by free fatty acids including linoleic, arachidonic, and oleic acids. Induction of peroxisomes by this mechanism leads to a reduction in blood triglyceride levels. PPAR alpha is expressed mainly in skeletal muscle, heart, liver, and kidney and is thought to regulate many genes involved in the beta-oxidation of fatty acids. Activation of rat liver PPAR alpha has been shown to suppress hepatocyte apoptosis. PPAR gamma 2, like several other nuclear hormone receptors, heterodimerizes with retinoic X receptor (RXR) alpha to form a transcriptionally competent complex.
  • Storage and Stability:Lyophilized powder may be stored at 4°C for short-term only. Stable for 12 months at -20°C. Reconstitute to nominal volume (see reconstitution instructions for peptides) and store at -20°C. For maximum recovery of product, centrifuge the original vial prior to removing the cap. Further dilutions can be made in assay buffer.

仕様

  • Size:1mg
  • Grade:Highly Purified
  • Purity:Highly purified ≥ 95%
  • Form:Lyophilized synthetic peptide. Reconstitute with 0.1ml ddH2O.
  • Calc Applications Abbrev:D E IHC WB
  • Calc Crossreactivity:Mo
  • EU Commodity Code:38220090
  • この商品は法規制を確認しておりません。(法規制によって販売できない場合もございます)
  • 製品の仕様は予告なく変更になる場合がございます。最新仕様はメーカーホームページをご確認ください。
  • 【試薬に関するお問合せ】
  • アズワン株式会社 試薬・プロセス材料グループ
  • TEL:06-6447-8641
  • FAX:06-6447-8642
  • E-mail:[email protected]
アズワン品番
85-1438-77
型番
P5505-02A
入り数
1個
標準価格
78,000円(税抜)
WEB価格
-円
アズワン在庫 [?]
数量

※お気に入り機能はログイン後にご利用いただけます

よくあるご質問

よくあるご質問(FAQ)

掲載カタログ情報

掲載カタログ名 掲載ページ

次の商品を登録しました。

商品計:

お買い物を続ける カートを見る